Tom Brokaws Cancer And His Hopeful Future

Today we work with the best scientists, pharmaceutical partners, biotech companies and academic centers in the world to facilitate progress in drug development. We remain eternally grateful for the work they do and the amazing trials of these pioneering drugs they produce so quickly. In the past decade myeloma patients have seen the FDA approve six multiple myeloma treatments, and counting an unthinkable timeline in oncology. As a result, we have witnessed the doubling of our patients life span. Our hope for the future is equally exciting due to the rapid advancement of technology in terms of genomic sequencing and the ability to store, integrate and share data in an open access world where patients have become more empowered in driving toward a cure. Were seeing today a more robust pipeline of treatments for the many subtypes of the disease than ever before.

Related post: